Home / Inspections / 1086471

FDA Inspection 1086471 — Catalent Pharma Solutions LLC

Catalent Pharma Solutions LLC — FEI 1000110912

The FDA completed an inspection of Catalent Pharma Solutions LLC on February 1, 2019 in Morrisville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 1, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Morrisville, NC (United States)

Additional Details

Bioanalytical BA/BE

Facility

Other inspections at this facility

  • 1303072 (VAI Fri May 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229061 (VAI Fri May 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1195585 (VAI Thu Dec 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1131607 (OAI Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1116748 (NAI Fri Dec 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources